What’s half a newspaper war? A newspaper tussle? Whatever it is, Denver is poised for one. Six years after floating an idea that Clarity Media might relaunch The Rocky Mountain News and challenge The Denver Post, conservative Denver billionaire Phil Anschutz’s media company is going for it. Kind of. The company will launch what it’s calling an Continue Reading
In the second quarter of 2020, enterprise clients made up more than 50% of WeWork’s core revenue for the first time in the company’s history. Your browser does not support inline frames or is currently configured not to display inline frames.
A Boulder outdoor-gear company that has grown steadily over its 10-year existence has made its first acquisition in the sector, hoping to overlap customers of the two companies as it pivots to more of an e-commerce focus for the foreseeable future. EcoVessel LLC, which manufactures reusable drinkware suitable for everything Continue Reading
Two unusual blocks of water rights came available, and the metro area’s No. 2 city spent tens of millions acquiring them. Your browser does not support inline frames or is currently configured not to display inline frames.
In 2007, my mom moved into a retirement community in my North Carolina hometown. She was only in her 70s, but she firmly believed in taking responsibility for her own future without “burdening the family,” so she chose a life care center that offered both independent living and a health Continue Reading
Denver area bankruptcy courts recorded four business filings – including zero with total debt above $1 million – during the week that ended August 21, 2020. Year to date through August 21, 2020, the court recorded 71 Chapter 7 or Chapter 11 business bankruptcy filings, a 15% increase from the Continue Reading
Arca Biopharma is in the process of developing a Covid-19 treatment. The Westminster-based biotech company, which focuses on genetically targeted therapies for cardiovascular diseases, plans to submit its Investigational New Drug application with the U.S. Food and Drug Administration in September. The application is for AB201, a drug that has Continue Reading